Groundbreaking study sheds light on the potential of the heart to achieve self-repair and regeneration

A groundbreaking scientific study published in Nature Cardiovascular Research has unveiled a remarkable discovery that may have far-reaching implications for the treatment of heart disease.

Daiichi Sankyo-AstraZeneca’s ENHERTU gains FDA BTD status

With the latest BTD, ENHERTU has now received eight designations, four of which are for metastatic breast cancer. Credit: Peakstock/Shutterstock. Daiichi Sankyo and AstraZeneca‘s ENHERTU

August 19, 2024

Astellas shows enough data for eye treatment to support expanded use, but still lags competitor

Astellas on Saturday presented study results showing an increased treatment effect over time for its approved medicine for a common type of vision loss. The

November 6, 2023

Saliva test offers hope for head and neck cancer patients

But what if a mouthwash-based test to detect biomarkers can help physicians predict disease recurrence in head and neck cancer patients?

August 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.